secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2026-08-10T20:10:18+00:00
Accession:  0001193125-26-342384
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q2 revenue down 9% to $55.2M; adjusted profit beats guidance
--------------------------------------------------------------------------------

- Q2 2026 revenue $55.2M, down 9% from $60.8M YoY; net loss improved to $(7.5)M from $(9.3)M.
- Adjusted EBITDA $14.6M (26% margin) vs $18.7M (31% margin) in Q2 2025; adjusted net income $7.5M.
- Operating cash flow $11.5M; unlevered free cash flow $11.6M; launched AI platform Turbo.
- Q3 2026 guidance: revenue $54.0-55.0M, adjusted EBITDA $13.5-14.5M; FY26 revenue $220-222M, adj EPS $0.18-0.20.
- Second consecutive quarter of YoY net dollar retention improvement; six-figure win-back deal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000119312526342384/0001193125-26-342384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000119312526342384/dh-20260810.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-342384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer